Ambee Pharmaceuticals PLC (DSE: AMBEEPHA)
Bangladesh
· Delayed Price · Currency is BDT
721.30
-24.80 (-3.32%)
At close: Nov 14, 2024
Ambee Pharmaceuticals Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
Cash & Equivalents | 34.24 | 28.57 | 16.92 | 15.09 | 11.12 | 5.57 | Upgrade
|
Cash & Short-Term Investments | 34.24 | 28.57 | 16.92 | 15.09 | 11.12 | 5.57 | Upgrade
|
Cash Growth | 120.59% | 68.81% | 12.12% | 35.79% | 99.64% | -56.02% | Upgrade
|
Receivables | 148.41 | 135.94 | 112.51 | 92.23 | 69.15 | 65.05 | Upgrade
|
Inventory | 208.53 | 197.25 | 178.89 | 128.89 | 160.25 | 144.53 | Upgrade
|
Prepaid Expenses | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
Other Current Assets | 79.65 | 64.65 | 100.76 | 85.62 | 81.02 | 78.69 | Upgrade
|
Total Current Assets | 470.86 | 426.44 | 409.11 | 321.85 | 321.57 | 293.86 | Upgrade
|
Property, Plant & Equipment | 85.16 | 87.61 | 95.04 | 99.56 | 106.48 | 109.13 | Upgrade
|
Other Long-Term Assets | - | - | - | 0 | - | - | Upgrade
|
Total Assets | 556.02 | 514.05 | 504.15 | 421.42 | 428.05 | 402.99 | Upgrade
|
Accounts Payable | 4.48 | 4.98 | 6.55 | 7.22 | 10.06 | 11.08 | Upgrade
|
Accrued Expenses | 41.99 | 53.1 | 53.02 | 79.04 | 82.33 | 65.38 | Upgrade
|
Short-Term Debt | 445.37 | 392.35 | 343.8 | 235.67 | 222.7 | 214.49 | Upgrade
|
Current Portion of Leases | 0.05 | 0.13 | 1.07 | 2.75 | 2.7 | 4.3 | Upgrade
|
Current Income Taxes Payable | 32.59 | 31.54 | 36.34 | 38.44 | 37.39 | 35.78 | Upgrade
|
Other Current Liabilities | 1.51 | 2.49 | 3.49 | 5 | 5.33 | 4.68 | Upgrade
|
Total Current Liabilities | 525.99 | 484.59 | 444.27 | 368.12 | 360.51 | 335.72 | Upgrade
|
Long-Term Leases | - | - | 0.01 | 1.42 | 2.33 | 1.8 | Upgrade
|
Long-Term Deferred Tax Liabilities | 5.47 | 6.12 | 7.17 | 7.04 | 7.36 | 7.66 | Upgrade
|
Other Long-Term Liabilities | - | -0 | - | - | - | - | Upgrade
|
Total Liabilities | 531.46 | 490.71 | 451.45 | 376.58 | 370.2 | 345.18 | Upgrade
|
Common Stock | 24 | 24 | 24 | 24 | 24 | 24 | Upgrade
|
Retained Earnings | 0.55 | -0.66 | 28.7 | 20.84 | 33.85 | 33.81 | Upgrade
|
Shareholders' Equity | 24.55 | 23.34 | 52.7 | 44.84 | 57.85 | 57.81 | Upgrade
|
Total Liabilities & Equity | 556.02 | 514.05 | 504.15 | 421.42 | 428.05 | 402.99 | Upgrade
|
Total Debt | 445.42 | 392.48 | 344.88 | 239.85 | 227.74 | 220.59 | Upgrade
|
Net Cash (Debt) | -411.18 | -363.91 | -327.96 | -224.75 | -216.62 | -215.03 | Upgrade
|
Net Cash Per Share | -171.33 | -151.63 | -136.65 | -93.65 | -90.26 | -89.59 | Upgrade
|
Filing Date Shares Outstanding | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | Upgrade
|
Total Common Shares Outstanding | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | Upgrade
|
Working Capital | -55.13 | -58.15 | -35.17 | -46.26 | -38.94 | -41.86 | Upgrade
|
Book Value Per Share | 10.23 | 9.73 | 21.96 | 18.68 | 24.10 | 24.09 | Upgrade
|
Tangible Book Value | 24.55 | 23.34 | 52.7 | 44.84 | 57.85 | 57.81 | Upgrade
|
Tangible Book Value Per Share | 10.23 | 9.73 | 21.96 | 18.68 | 24.10 | 24.09 | Upgrade
|
Land | 50.25 | 50.25 | 50.25 | 50.25 | 50.25 | 50.25 | Upgrade
|
Buildings | 29.95 | 29.95 | 29.95 | 29.08 | 29.08 | 29.08 | Upgrade
|
Machinery | 150.16 | 148.26 | 148.15 | 147.49 | 147.49 | 146.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.